Investigating Runner’s High: Changes in Mood and Endocannabinoid Concentrations after a 60 min Outdoor Run Considering Sex, Running Frequency, and Age
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Procedures and Participants
2.2. Blood Sampling
2.3. Chemicals
2.4. Endocannabinoid Measurement
2.5. Questionnaire and Statistical Analysis
3. Results
3.1. Pre- and Post-Run Mood and Mood Increase Considering Sex, Running Frequency, and Age
3.2. Pre- and Post-Run AEA and 2-AG Concentrations and Increase in AEA and 2-AG Concentrations Considering Sex, Running Frequency, and Age
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Siebers, M.; Biedermann, S.V.; Fuss, J. Do Endocannabinoids Cause the Runner’s High? Evidence and Open Questions. Neuroscientist 2022, 29, 352–369. [Google Scholar] [CrossRef]
- Tasker, J. Endogenous Cannabinoids Take the Edge off Neuroendocrine Responses to Stress. Endocrinology 2004, 145, 5429–5430. [Google Scholar] [CrossRef]
- Carrier, E.; Patel, S.; Hillard, C. Endocannabinoids in Neuroimmunology and Stress. Curr. Drug Target CNS Neurol. Disord. 2005, 4, 657–665. [Google Scholar] [CrossRef]
- Hohmann, A.G.; Suplita, R.L.; Bolton, N.M.; Neely, M.H.; Fegley, D.; Mangieri, R.; Krey, J.F.; Walker, J.M.; Holmes, P.V.; Crystal, J.D.; et al. An endocannabinoid mechanism for stress-induced analgesia. Nature 2005, 435, 1108–1112. [Google Scholar] [CrossRef]
- Dietrich, A.; McDaniel, W.F. Endocannabinoids and exercise. Br. J. Sports Med. 2004, 38, 536–541. [Google Scholar] [CrossRef]
- Watkins, B.A. Endocannabinoids, exercise, pain, and a path to health with aging. Mol. Asp. Med. 2018, 64, 68–78. [Google Scholar] [CrossRef]
- Siebers, M.; Biedermann, S.V.; Bindila, L.; Lutz, B.; Fuss, J. Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans. Psychoneuroendocrinology 2021, 126, 105173. [Google Scholar] [CrossRef]
- Fuss, J.; Steinle, J.; Bindila, L.; Auer, M.K.; Kirchherr, H.; Lutz, B.; Gass, P. A runner’s high depends on cannabinoid receptors in mice. Proc. Natl. Acad. Sci. USA 2015, 112, 13105–13108. [Google Scholar] [CrossRef]
- Savinainen, J.R.; Järvinen, T.; Laine, K.; Laitinen, J.T. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor-dependent G-protein activation in rat cerebellar membranes. Br. J. Pharmacol. 2001, 134, 664–672. [Google Scholar] [CrossRef]
- Mackie, K. Mechanisms of CB1 receptor signaling: Endocannabinoid modulation of synaptic strength. Int. J. Obes. 2006, 30, S19–S23. [Google Scholar] [CrossRef] [PubMed]
- Sugiura, T.; Kishimoto, S.; Oka, S.; Gokoh, M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res. 2006, 45, 405–446. [Google Scholar] [CrossRef] [PubMed]
- Dubreucq, S.; Koehl, M.; Abrous, D.N.; Marsicano, G.; Chaouloff, F. CB1 receptor deficiency decreases wheel-running activity: Consequences on emotional behaviours and hippocampal neurogenesis. Exp. Neurol. 2010, 224, 106–113. [Google Scholar] [CrossRef] [PubMed]
- Dubreucq, S.; Durand, A.; Matias, I.; Bénard, G.; Richard, E.; Soria-Gomez, E.; Glangetas, C.; Groc, L.; Wadleigh, A.; Massa, F.; et al. Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance. Biol. Psychiatry 2013, 73, 895–903. [Google Scholar] [CrossRef]
- Galdino, G.; Romero, T.R.; Silva, J.F.P.; Aguiar, D.C.; de Paula, A.M.; Cruz, J.S.; Parrella, C.; Piscitelli, F.; Duarte, I.D.; Di Marzo, V.; et al. The endocannabinoid system mediates aerobic exercise-induced antinociception in rats. Neuropharmacology 2014, 77, 313–324. [Google Scholar] [CrossRef]
- Sparling, P.B.; Giuffrida, A.; Piomelli, D.; Rosskopf, L.; Dietrich, A. Exercise activates the endocannabinoid system. Neuroreport 2003, 14, 256–277. [Google Scholar] [CrossRef]
- Stone, N.L.; Millar, S.A.; Herrod, P.J.J.; Barrett, D.A.; Ortori, C.A.; Mellon, V.A.; O’Sullivan, S.E. An Analysis of Endocannabinoid Concentrations and Mood Following Singing and Exercise in Healthy Volunteers. Front. Behav. Neurosci. 2018, 12, 269. [Google Scholar] [CrossRef]
- Raichlen, D.A.; Foster, A.D.; Seillier, A.; Giuffrida, A.; Gerdeman, G.L. Exercise-induced endocannabinoid signaling is modulated by intensity. Eur. J. Appl. Physiol. 2013, 113, 869–875. [Google Scholar] [CrossRef] [PubMed]
- Crombie, K.M.; Brellenthin, A.G.; Hillard, C.J.; Koltyn, K.F. Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder. J. Trauma. Stress 2018, 31, 134–145. [Google Scholar] [CrossRef] [PubMed]
- Crombie, K.M.; Leitzelar, B.N.; Brellenthin, A.G.; Hillard, C.J.; Koltyn, K.F. Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol concentrations in adults with chronic PTSD. Biol. Psychol. 2019, 145, 1–7. [Google Scholar] [CrossRef]
- Brellenthin, A.G.; Crombie, K.M.; Hillard, C.J.; Koltyn, K.F. Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels. Med. Sci. Sports Exerc. 2017, 49, 1688–1696. [Google Scholar] [CrossRef]
- Feuerecker, M.; Hauer, D.; Toth, R.; Demetz, F.; Hölzl, J.; Thiel, M.; Kaufmann, I.; Schelling, G.; Choukèr, A. Effects of exercise stress on the endocannabinoid system in humans under field conditions. Eur. J. Appl. Physiol. 2012, 112, 2777–2781. [Google Scholar] [CrossRef]
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonized tripartite guideline: Guideline for Good Clinical Practice. J. Postgrad. Med. 2001, 47, 45–50. [Google Scholar]
- Berger, B.G.; Motl, R.W. Exercise and mood: A selective review and synthesis of research employing the profile of mood states. J. Appl. Sport. Psychol. 2000, 12, 69–92. [Google Scholar] [CrossRef]
- Reed, J.; Ones, D.S. The effect of acute aerobic exercise on positive activated affect: A meta-analysis. Psychol. Sport. Exerc. 2006, 7, 477–514. [Google Scholar] [CrossRef]
- Raichlen, D.A.; Foster, A.D.; Gerdeman, G.L.; Seillier, A.; Giuffrida, A. Wired to run: Exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the ‘runner’s high’. J. Exp. Biol. 2012, 215, 1331–1336. [Google Scholar] [CrossRef]
- Weiermair, T.; Svehlikova, E.; Magnes, C.; Boulgaropoulos, B.; Altendorfer-Kroath, T.; Hummer, J.; Eberl, A. Implementation and validation of a UHPLC-MS/MS method for quantification of the endocannabinoids AEA and 2-AG in cerebral interstitial fluid and plasma. J. Pharm. Biomed. Anal. 2024, 238, 115844. [Google Scholar] [CrossRef]
- Roa, E.; Ettenberger, M. Music Therapy Self-Care Group for Parents of Preterm Infants in the Neonatal Intensive Care Unit: A Clinical Pilot Intervention. Medicines 2018, 5, 134. [Google Scholar] [CrossRef]
- Ferraz, M.B.; Quaresma, M.R.; Aquino, L.R.; Atra, E.; Tugwell, P.; Goldsmith, C.H. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J. Rheumatol. 1990, 17, 1022–1024. [Google Scholar]
- Hawker, G.A.; Mian, S.; Kendzerska, T.; French, M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthr. Care Res. 2011, 63, S240–S252. [Google Scholar] [CrossRef]
- Scherpenzeel, A.C.; Saris, W.E. The Validity and Reliability of Survey Questions. Sociol. Methods Res. 1997, 25, 341–383. [Google Scholar] [CrossRef]
- Hillard, C.J. Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? Neuropsychopharmacology 2018, 43, 155–172. [Google Scholar] [CrossRef] [PubMed]
- Antunes, H.K.M.; Leite, G.S.F.; Lee, K.S.; Barreto, A.T.; dos Santos, R.V.T.; Souza, H.d.S.; Tufik, S.; de Mello, M.T. Exercise deprivation increases negative mood in exercise-addicted subjects and modifies their biochemical markers. Physiol. Behav. 2016, 156, 182–190. [Google Scholar] [CrossRef] [PubMed]
- Heyman, E.; Gamelin, F.-X.; Goekint, M.; Piscitelli, F.; Roelands, B.; Leclair, E.; Di Marzo, V.; Meeusen, R. Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression. Psychoneuroendocrinology 2012, 37, 844–851. [Google Scholar] [CrossRef] [PubMed]
- Koltyn, K.F.; Brellenthin, A.G.; Cook, D.B.; Sehgal, N.; Hillard, C. Mechanisms of Exercise-Induced Hypoalgesia. J. Pain 2014, 15, 1294–1304. [Google Scholar] [CrossRef] [PubMed]
- Koay, Y.C.; Stanton, K.; Kienzle, V.; Li, M.; Yang, J.; Celermajer, D.S.; O’Sullivan, J.F. Effect of chronic exercise in healthy young male adults: A metabolomic analysis. Cardiovasc. Res. 2021, 117, 613–622. [Google Scholar] [CrossRef]
- Thompson, Z.; Argueta, D.; Garland, T.; DiPatrizio, N. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes. Physiol. Behav. 2017, 170, 141–150. [Google Scholar] [CrossRef]
- Almeida, M.M.; Dias-Rocha, C.P.; Calviño, C.; Trevenzoli, I.H. Lipid endocannabinoids in energy metabolism, stress and developmental programming. Mol. Cell. Endocrinol. 2022, 542, 111522. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Weiermair, T.; Svehlikova, E.; Boulgaropoulos, B.; Magnes, C.; Eberl, A. Investigating Runner’s High: Changes in Mood and Endocannabinoid Concentrations after a 60 min Outdoor Run Considering Sex, Running Frequency, and Age. Sports 2024, 12, 232. https://doi.org/10.3390/sports12090232
Weiermair T, Svehlikova E, Boulgaropoulos B, Magnes C, Eberl A. Investigating Runner’s High: Changes in Mood and Endocannabinoid Concentrations after a 60 min Outdoor Run Considering Sex, Running Frequency, and Age. Sports. 2024; 12(9):232. https://doi.org/10.3390/sports12090232
Chicago/Turabian StyleWeiermair, Theresia, Eva Svehlikova, Beate Boulgaropoulos, Christoph Magnes, and Anita Eberl. 2024. "Investigating Runner’s High: Changes in Mood and Endocannabinoid Concentrations after a 60 min Outdoor Run Considering Sex, Running Frequency, and Age" Sports 12, no. 9: 232. https://doi.org/10.3390/sports12090232
APA StyleWeiermair, T., Svehlikova, E., Boulgaropoulos, B., Magnes, C., & Eberl, A. (2024). Investigating Runner’s High: Changes in Mood and Endocannabinoid Concentrations after a 60 min Outdoor Run Considering Sex, Running Frequency, and Age. Sports, 12(9), 232. https://doi.org/10.3390/sports12090232